The UTHealth Medical-Legal Partnership: Improving Health by Addressing Health-Harming Legal Needs

NCT ID: NCT03364543

Last Updated: 2020-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

911 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-16

Study Completion Date

2019-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the acceptability, feasibility, and preliminary effectiveness of the UTHealth medical-legal partnerships (MLP) against usual care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Social Determinants of Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Medical-Legal Partnership Group

The Medical-Legal Partnership Group are lawyers in clinics who address health-harming legal needs. This group will also have access to access to a social worker and a community worker.

Access to the Medical-Legal Partnership Group

Intervention Type OTHER

The Medical-Legal Partnership Group are lawyers in clinics who address health-harming legal needs.

Access to social worker and a community worker

Intervention Type OTHER

Access to social worker and a community worker, but no systematic process for addressing health-harming legal needs.

Usual Care

Access to a social worker and a community worker, but no systematic process for addressing health-harming legal needs.

Access to social worker and a community worker

Intervention Type OTHER

Access to social worker and a community worker, but no systematic process for addressing health-harming legal needs.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Access to the Medical-Legal Partnership Group

The Medical-Legal Partnership Group are lawyers in clinics who address health-harming legal needs.

Intervention Type OTHER

Access to social worker and a community worker

Access to social worker and a community worker, but no systematic process for addressing health-harming legal needs.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* English- or Spanish- speaking
* screen positive for health-harming legal needs (HHLNs)

Exclusion Criteria

* Those unable or unwilling to consent to legal services
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Winston Liaw

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Winston Liaw

Role: PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center, Houston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Texas Health Science Center at Houston

Houston, Texas, United States

Site Status

UTHealth Comprehensive Sickle Cell Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-048

Identifier Type: -

Identifier Source: org_study_id